{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:17:16Z","timestamp":1762431436606},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.clineuro.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T12:32:45Z","timestamp":1526387565000},"page":"106-112","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Evaluation ofserum free carnitine\/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid"],"prefix":"10.1016","volume":"170","author":[{"given":"Ilknur","family":"Kulhas Celik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haydar Ali","family":"Tasdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fclya","family":"Ince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"Sungur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2018.05.005_bib0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0010","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1528-1167.2006.00846.x","article-title":"Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003","volume":"47","author":"Koenig","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","article-title":"Carnitine deficiency and hyperammonemia associated with valproic acid treatment","volume":"101","author":"Ohtani","year":"1982","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1528-1157.1986.tb03584.x","article-title":"Serum carnitine during valproic acid treatment","volume":"27","author":"Laub","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-3476(05)80931-X","article-title":"Carnitine deficiency caused by valproic acid","volume":"120","author":"Castro-Gago","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s005990050060","article-title":"Carnitine deficiency and hyperammonenia in children receiving valproic acid with and without other anticonvulsant drugs","volume":"29","author":"Verroti","year":"1999","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0006-2952(96)00507-2","article-title":"Inhibition of carnitine biosynthesis by valproic acid in rats\u2013the biochemical mechanism of inhibition","volume":"52","author":"Farkas","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0887-8994(86)90062-7","article-title":"Carnitine status in Reye and Reye-like syndromes","volume":"2","author":"Matsuda","year":"1986","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0045","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.41.9.1444","article-title":"Alternation of renal carnitine metabolism by anticonvulsant treatment","volume":"41","author":"Cami\u00f1a","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/cc3742","article-title":"Science review: carnitine in the treatment of valproic acid-induced toxicity\u2014what is the evidence?","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit. Care"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0055","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitine-metabolism and functions","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0060","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00126839-200607030-00002","article-title":"Hypocarnitinaemia induced by sodium pivalate in the rat is associated with left ventricular dysfunction and impaired energy metabolism","volume":"7","author":"Broderick","year":"2006","journal-title":"Drugs R D"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0070","first-page":"215","article-title":"Effect of concentration carnitine on acetylcarnitine production in rat heart mitochondria oxidizing pyruvate","volume":"4","author":"Lysiak","year":"1998","journal-title":"Nutrition"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0075","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1016\/S0021-9258(19)50590-7","article-title":"Carnitine stimulation of glucose oxidation in the fatty acid-perfused isolated working rat heart","volume":"267","author":"Broderick","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0080","first-page":"999","article-title":"The effect of valproic acid on plasma carnitine levels","volume":"145","author":"Opala","year":"1991","journal-title":"Am. J. Dis. Child"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/0883073808321060","article-title":"Serum and muscle carnitine levels in epileptic children receiving sodium valproate","volume":"24","author":"Anil","year":"2009","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1528-1167.2006.00833.x","article-title":"Effect of valproate on acylcarnitines in children with epilepsy using ESI-MS\/MS","volume":"48","author":"Werner","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0095","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/088307389801301104","article-title":"Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital","volume":"13","author":"Castro-Gago","year":"1998","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1157.1993.tb02396.x","article-title":"Carnitine disposition before and valproate treatment in patients with epilepsy","volume":"34","author":"Riva","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.braindev.2005.11.005","article-title":"Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet","volume":"28","author":"Coppola","year":"2006","journal-title":"Brain Dev."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0009-9120(01)00272-7","article-title":"Characterization of plasma acylcarnitines in patients under valproate monotreatment using ESI-MS\/MS","volume":"34","author":"Silva","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0887-8994(02)00460-5","article-title":"Carnitine level in Chinese epileptic patients taking sodium valproate","volume":"28","author":"Fung","year":"2003","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2018.05.005_bib0120","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1542\/peds.101.5.e9","article-title":"Valproate treatment does not deplete carnitine levels in otherwise healthy children","volume":"101","author":"Hirose","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.clineuro.2018.05.005_bib0125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/mgme.2001.3200","article-title":"Valproate induces in vitro accumulation of long-chain fatty acylcarnitines","volume":"73","author":"Silva","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.clineuro.2018.05.005_bib0130","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1542\/peds.111.6.1399","article-title":"Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome and implications","volume":"111","author":"Schulze","year":"2003","journal-title":"Pediatrics"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718301872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718301872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T18:38:27Z","timestamp":1661279907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846718301872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":26,"alternative-id":["S0303846718301872"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.05.005","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation ofserum free carnitine\/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}